Related references
Note: Only part of the references are listed.Pathologic Complete Responses After Chemotherapy Plus Figitumumab in Stage IV Non-Small-Cell Lung Cancer
Jesus Corral et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples
Jefferson Terry et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
The Emerging Role of Histology in the Choice of First-Line Treatment of Advanced Non-Small Cell Lung Cancer: Implication in the Clinical Decision-Making
A. Rossi et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma
Justin A. Bishop et al.
HUMAN PATHOLOGY (2010)
Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens
Peh Sun Loo et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis
Andrew G. Nicholson et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Value of P63 and CK5/6 in Distinguishing Squamous Cell Carcinoma From Adenocarcinoma in Lung Fine-Needle Aspiration Specimens
Said Khayyata et al.
DIAGNOSTIC CYTOPATHOLOGY (2009)
被撤回的出版物: Phase II Study of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non-Small-Cell Lung Cancer (Retracted article. See vol. 30, pg. 4179, 2012)
Daniel D. Karp et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung
Valentina Monica et al.
MODERN PATHOLOGY (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Giorgio Scagliotti et al.
ONCOLOGIST (2009)
Lung adenocarcinoma:: Modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis
Noriko Motoi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas
Aydanur Kargi et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
FDA drug approval summary: Bevacizumab (Avastin (R)) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer
Martin H. Cohen et al.
ONCOLOGIST (2007)
Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas
R Camilo et al.
HUMAN PATHOLOGY (2006)
p63 expression in lung carcinoma - A tissue microarray study of 408 cases
NHC Au et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2004)
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
DH Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
TTF-1 expression in pulmonary adenocarcinomas
Y Yatabe et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Thyroid transcription factor-1: A review
SK Lau et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2002)
Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases
PGG Chu et al.
MODERN PATHOLOGY (2002)
Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases
PG Chu et al.
MODERN PATHOLOGY (2000)
Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category
SL Edwards et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
